Important Information

We want to make investing with us simple and straightforward for all of our clients.

Please select your investor type from the options below.

Alternatively you can register or log in to an existing account.

Please note that by making your selection here you are agreeing to the Woodford Investment Management Ltd Privacy Statement and to our Terms and Conditions.

Register now to receive Blog alerts by email.

Home > Words > Blog

UK economy – defiant growth

Mitchell Fraser-Jones 20 September 2017 3 min read

We remain positive on the outlook for the UK economy which, as these three charts reaffirm, is in better shape than many believe…

Read more

Neil Woodford: a summer in perspective

Mitchell Fraser-Jones 6 September 2017 19 min read

We have always encouraged dialogue with our investors and understandably some have been in touch, not only to express their disappointment, but also to seek answers as to why the fund’s recent performance has suffered. In the following video, Neil explains events and what they mean for the fund’s strategy

Read more

Update on Provident Financial

Neil Woodford 22 August 2017 4 min read

This morning we have received another profit warning from Provident Financial, which has led to a substantial share price decline. Neil gives his latest view.

Read more

Update on AstraZeneca

Neil Woodford 27 July 2017 4 min read

Earlier today, AstraZeneca announced initial trial data from its phase III Mystic study for its potential combination therapy for lung cancer. Neil gives his view on the announcement.

Read more

Another election, another surprise

Neil Woodford 9 June 2017 3 min read

So we’ve had another election and received another surprise. In all the heat and light that accompanies an unexpected political outcome, a lot of extreme conclusions have been discussed by market and media commentators. From where I’m sitting, however, economically not a lot has changed. In fact, in some respects, the outlook for the UK economy has improved…

Read more


Neil Woodford 12 May 2017 4 min read

Over a holding period of more than fifteen years, we have consistently believed that GlaxoSmithKline was capable of delivering growth and realising shareholder value.

Read more

Woodford Patient Capital Trust annual report

Neil Woodford 21 April 2017 8 min read

Today marks the publication of the Woodford Patient Capital Trust annual report. You can download the full report here, but below is Neil’s review of the trust’s progress in 2016. Download as a PDF We began 2016 with the money raised at the launch of WPCT fully deployed – and so the period under review

Read more

Income Focus Fund now live

Mitchell Fraser-Jones 19 April 2017 1 min read

The offer period for the CF Woodford Income Focus Fund closed on 12 April 2017 and we can now confirm that £553m has been raised. Daily pricing of the fund has now commenced (you can find the latest price here), and Neil has been busy building the portfolio over the last few days, a process

Read more

A great time to be investing in equities

Neil Woodford 5 April 2017 6 min read

Whilst travelling around the country recently for the launch of the Income Focus Fund, Neil has regularly been asked why this an appropriate time to be launching a new equity-based fund.

Read more

Is cash king?

Mitchell Fraser-Jones 31 March 2017 8 min read

The saying goes, cash is king. Yet £10,000 invested in cash 10 years ago is worth £8,600 in real terms – a loss of 14%! Cash has its uses but perhaps sitting in a cash ISA for years on end isn’t one of them. Is it time to reassess your risk versus return?

Read more

Woodford Investment Management Ltd is authorised and regulated by the Financial Conduct Authority (firm reference number 745433). Incorporated in England and Wales, company number 10118169. Registered address 9400 Garsington Road, Oxford OX4 2HN.

Woodford Patient Capital Trust plc is incorporated in England and Wales, company number 09405653. Registered as an investment company under section 833 of the Companies Act 2006. Registered address 40 Dukes Place, London EC3A 7NH.

The Woodford Funds (Ireland) ICAV (the “Fund”) has appointed as Swiss Representative Oligo Swiss Fund Services SA, Av. Villamont 17, 1005 Lausanne, Switzerland, Tel: +41 21 311 17 77, email: The Fund’s Swiss paying agent is Neue Helvetische Bank AG. All fund documentation including, Prospectus, Key Investor Information Documents, Instrument of Incorporation and financial reports may be obtained free of charge from the Swiss Representative in Lausanne. The place of performance and jurisdiction for all shares distributed in or from Switzerland is at the registered office of the Swiss Representative. Fund prices can be found at

© 2017 Woodford Investment Management Ltd.
All rights reserved.

By using this website you are automatically agreeing to the Woodford Investment Management Ltd privacy statement